Lifecore Biomedical, Inc. (LFCR): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-05-27 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

37.03M
As of 2025-05-25
37.70M
As of 2026-06-30
+7.9%
3-year compound annual growth
+4.8%
5-year compound annual growth
+3.2%
10-year compound annual growth
2011-05-29: 26.41M2012-05-27: 25.64M2013-05-26: 26.40M2014-05-25: 26.82M2015-05-31: 26.99M2016-05-29: 27.15M2017-05-28: 27.50M2018-05-27: 27.70M2019-05-26: 29.10M2020-05-31: 29.22M2021-05-30: 29.33M2022-05-29: 29.51M2023-05-28: 30.32M2024-05-26: 30.56M2025-05-25: 37.03M37.03M
2011-05-29 Shares Outstanding (shares) 2025-05-25
Period endedShares OutstandingChange YoYSource filing
2025-05-2537.03M+21.1%2025-08-07, Balance as of period end
2024-05-2630.56M+0.8%2025-08-07, Balance as of period end
2023-05-2830.32M+2.7%2024-08-26, Balance as of period end
2022-05-2929.51M+0.6%2024-03-20, Balance as of period end
2021-05-3029.33M+0.4%2023-03-16, Balance as of period end
2020-05-3129.22M+0.4%2021-07-29, Balance as of period end
2019-05-2629.10M+5.1%2020-08-14, Balance as of period end
2018-05-2727.70M+0.7%2019-08-01, Balance as of period end
2017-05-2827.50M+1.3%2018-08-09, Balance as of period end
2016-05-2927.15M+0.6%2018-03-15, Balance as of period end
2015-05-3126.99M+0.7%2016-08-01, Balance as of period end
2014-05-2526.82M+1.6%2015-07-31, Balance as of period end
2013-05-2626.40M+3.0%2014-08-01, Balance as of period end
2012-05-2725.64Mn/c2013-08-07, Balance as of period end
2011-05-2926.41Mn/a2012-08-08, Balance as of period end